Literature DB >> 24662488

Impact of new hepatitis C treatments in different regions of the world.

Lai Wei1, Anna S F Lok2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24662488     DOI： 10.1053/j.gastro.2014.03.008

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  23 in total

1.  Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.

Authors:  Kieron B L Lim; Hamid R Sima; M Isabel Fiel; Viktoriya Khaitova; John T Doucette; Maria Chernyiak; Jawad Ahmad; Nancy Bach; Charissa Chang; Priya Grewal; Leona Kim-Schluger; Lawrence Liu; Joseph Odin; Ponni Perumalswami; Sander S Florman; Thomas D Schiano
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

2.  Individualized treatment strategies and predictors of virological response for chronic hepatitis C: a multicenter prospective study from China.

Authors:  Yue-Min Nan; Yu-Guo Zhang; Huan-Wei Zheng; Chun-Mian An; You-Sheng Li; Ying Zhang; Dian-Xing Sun; Cang-You Li; Qiang Li; Li-Xin Tong; Ling-Bo Kong; Su-Xian Zhao; Rong-Qi Wang; Ping Meng; Shan-Shan Su; Huan He; Xue-Min Niu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  Hepatitis C virus: A time for decisions. Who should be treated and when?

Authors:  Bashar M Attar; David H Van Thiel
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 4.  A 2015 roadmap for the management of hepatitis C virus infections in Asia.

Authors:  Seng Gee Lim; Yock Young Dan
Journal:  Korean J Intern Med       Date:  2015-06-29       Impact factor: 2.884

Review 5.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

6.  Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6.

Authors:  Ruifeng Yang; Xu Cong; Shaocai Du; Ran Fei; Huiying Rao; Lai Wei
Journal:  J Clin Microbiol       Date:  2014-08-06       Impact factor: 5.948

Review 7.  Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?

Authors:  Drosos E Karageorgopoulos; Joanna Allen; Sanjay Bhagani
Journal:  World J Hepatol       Date:  2015-07-28

8.  Direct-acting antiviral treatments display excellent outcomes even in older HCV-infected patients at increased risk of fibrosis.

Authors:  Huan Xia; Yaping Zhang; Silvere D Zaongo; Jing Liang; Xiaowen Gong; Yue Hu; Ping Ma; Fengmei Wang
Journal:  Ann Transl Med       Date:  2021-05

Review 9.  A New Twist to a Chronic HCV Infection: Occult Hepatitis C.

Authors:  Bashar M Attar; David Van Thiel
Journal:  Gastroenterol Res Pract       Date:  2015-06-24       Impact factor: 2.260

Review 10.  Hepatocellular Carcinoma in Pakistan: National Trends and Global Perspective.

Authors:  Abu Bakar Hafeez Bhatti; Faisal Saud Dar; Anum Waheed; Kashif Shafique; Faisal Sultan; Najmul Hassan Shah
Journal:  Gastroenterol Res Pract       Date:  2016-02-03       Impact factor: 2.260
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.